Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 23:11:1139617.
doi: 10.3389/fpubh.2023.1139617. eCollection 2023.

Interventions for reducing blood pressure in prehypertension: A meta-analysis

Wenjing Li  1 , Hao Liu  1 , Xinai Wang  1 , Jingying Liu  2 , Hongling Xiao  2 , Chenqi Wang  1 , Yaxuan Wu  1
Affiliations

Interventions for reducing blood pressure in prehypertension: A meta-analysis

Wenjing Li et al. Front Public Health. .

Abstract

Background: We aimed to address which interventions best control blood pressure (BP) and delay disease progression in prehypertension and to give recommendations for the best option following a quality rating.

Methods: A Bayesian network meta-analysis was used to assess the effect of the intervention on BP reduction, delaying hypertension progression and final outcome, with subgroup analyses for time and ethnicity. Recommendations for interventions were finally based on cumulative ranking probabilities and CINeMA.

Results: From 22,559 relevant articles, 101 eligible randomized controlled trial articles (20,176 prehypertensive subjects) were included and 30 pharmacological and non-pharmacological interventions were evaluated. Moderate-quality evidence demonstrated that angiotensin II receptor blockers, aerobic exercise (AE), and dietary approaches to stop hypertension (DASH) lowered systolic blood pressure (SBP). For lowering diastolic blood pressure (DBP), AE combined with resistance exercise (RE) or AE alone provided high quality evidence, with calcium channel blockers, lifestyle modification (LSM) combined with drug providing moderate quality evidence. LSM produced the best BP lowering effect at 12 months and beyond of intervention. In Asians, TCD bubble was moderate quality evidence for lowering SBP and RE may have had a BP lowering effect in Caucasians. No recommendation can be given for delaying the progression of hypertension and reducing mortality outcomes because of low to very low quality of evidence.

Conclusion: AE combined RE are preferentially recommended for BP control in prehypertension, followed by DASH. Long-term BP control is preferred to LSM. Asians and Caucasians add TCD bubble and RE to this list as potentially effective interventions.

Systematic review registration: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022356302, identifier: CRD42022356302.

Keywords: aerobic exercise; dietary approaches to stop hypertension (DASH); hypertension; meta-analysis; prehypertension.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Database search and selection process.
Figure 2
Figure 2
Network geometry and forest plot in PHT with four outcomes. (A) SBP (106 trails, 17,354 patients), (B) DBP (104 trails, 17,291 patients), (C) HT progression (26 trails, 9,959 patients), (D) Cardiac, cerebral, renal, and mortality outcomes (five trails, 2,945 patients). The difference among each comparison is visualized with forest plot, and the effect size is labeled on the right-hand side. AE, aerobic exercise; HIIT, high-intensity interval training; RE, resistance exercise; DASH, dietary approaches to stop hypertension; TPM, Traditional Persian Medicine; TCD, traditional Chinese drug; EMG, electromyographic; MBSR, mindfulness-based stress reduction; LSM, lifestyle modification; TCM, Traditional Chinese Medicine; ARB, angiotensin II receptor blockers; ACE, angiotensin-converting enzyme inhibitors; CCB, calcium channel blockers.
See this image and copyright information in PMC

References

    1. Kahan T. Decisions about antihypertensive treatment should focus on reducing cardiovascular risk. Lancet. (2021) 397:1598–9. 10.1016/S0140-6736(21)00877-1 - DOI - PubMed
    1. Chobanian AV, Bakris GL, Black HR, Cushmann WC, Green LA, Izzo JL, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report. J Am Med Assoc. (2003) 289:2560–72. 10.1001/jama.289.19.2560 - DOI - PubMed
    1. 中国高血压防治指南(2018 年修订版). 中国心血管杂志. (2019) 24:24–56. 10.3969/j.issn.1007-5410.2019.01.002 - DOI
    1. Balouchi A, Rafsanjani MHAP, Al-Mutawaa K, Naderifar M, Rafiemanesh H, Ebadi A, et al. Hypertension and Pre-Hypertension in Middle East and North Africa (MENA): A meta-analysis of prevalence, awareness, treatment, and control. Curr Probl Cardiol. (2022) 47:101069. 10.1016/j.cpcardiol.2021.101069 - DOI - PubMed
    1. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Himmelfarb CD, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. (2018) 138:e426–83. 10.1161/cir.0000000000000597 - DOI - PubMed

Publication types